Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS)

100 filings reported holding ABOS - Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share as of Q2 2025.
Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 37.6M shares of 60.7M outstanding shares and own 61.96% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (14.9M shares), Sands Capital Alternatives, LLC (3.42M shares), FRANKLIN RESOURCES INC (3.08M shares), FMR LLC (2.03M shares), MILLENNIUM MANAGEMENT LLC (1.95M shares), VANGUARD GROUP INC (1.69M shares), Knollwood Investment Advisory, LLC (1.63M shares), Pathstone Holdings, LLC (1.06M shares), Alyeska Investment Group, L.P. (940K shares), and ADAR1 Capital Management, LLC (916K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.